Thank you for sharing!

Your article was successfully shared with the contacts you provided.
The Takeda Pharmaceutical Co. logo is displayed atop the company’s global headquarters in Tokyo. Photo: Kiyoshi Ota/Bloomberg

Attorneys with Keker, Van Nest & Peters are entitled to more than $19 million in disputed fees for their contingent representation of former shareholders, Vice Chancellor Kathaleen McCormick has ruled.

Those fees are included in an over $80 million judgment leveled against Shire U.S. Holdings Inc. in a case that took the uncommon path of going to trial while plaintiffs were represented on contingency.

Want to continue reading?
Become a Free ALM Digital Reader.

Benefits of a Digital Membership:

  • Free access to 1 article* every 30 days
  • Access to the entire ALM network of websites
  • Unlimited access to the ALM suite of newsletters
  • Build custom alerts on any search topic of your choosing
  • Search by a wide range of topics

*May exclude premium content
Already have an account?

Ellen Bardash

Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.